Biggest change(Back to Index) 44 (Back to Index) The following table presents information about our common stock repurchases made during the year ended December 31, 2022 in accordance with our repurchase program (dollars in thousands, except per share amounts): Common Stock Total Number of Shares Purchased Average Price Paid per Share (1) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that may yet be Purchased under the Plans or Programs January 3, 2022 - January 31, 2022 153,522 $ 12.53 153,522 $ 14,409 February 1, 2022 - February 28, 2022 85,777 12.05 85,777 13,377 March 1, 2022 - March 31, 2022 75,253 12.33 75,253 12,450 April 1, 2022 - April 29, 2022 60,410 13.06 60,410 11,662 May 2, 2022 - May 31, 2022 45,743 10.91 45,743 11,164 June 1, 2022 - June 30, 2022 131,577 9.19 131,577 9,957 July 1, 2022 - July 29, 2022 58,719 8.22 58,719 9,476 August 1, 2022 - August 31, 2022 81,586 9.58 81,586 8,696 September 1, 2022 - September 30, 2022 58,122 9.43 58,122 8,149 October 3, 2022 - October 31, 2022 39,057 8.69 39,057 7,810 November 1, 2022 - November 30, 2022 42,940 10.14 42,940 7,376 December 1, 2022 - December 31, 2022 16,272 9.76 16,272 7,217 Total 848,978 $ 10.75 848,978 (1) The average price paid per share as reflected above includes broker fees and commissions.
Biggest change(Back to Index) 42 (Back to Index) The following table presents information about our common stock repurchases made during the year ended December 31, 2023 in accordance with our repurchase program (dollars in thousands, except per share amounts): Common Stock Total Number of Shares Purchased Average Price Paid per Share (1) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs Approximate Dollar Value of Shares that may yet be Purchased under the Plans or Programs January 19, 2023 - January 31, 2023 9,822 $ 9.78 9,822 $ 7,121 February 1, 2023 - February 28, 2023 24,754 9.48 24,754 6,887 March 1, 2023 - March 31, 2023 45,168 9.39 45,168 6,464 April 3, 2023 - April 28, 2023 45,645 9.48 45,645 6,032 May 1, 2023 - May 31, 2023 62,001 8.61 62,001 5,499 June 1, 2023 - June 30, 2023 27,770 8.41 27,770 5,266 July 3, 2023 - July 31, 2023 29,242 9.01 29,242 5,003 August 1, 2023 - August 31, 2023 36,137 8.77 36,137 4,687 September 4, 2023 - September 29, 2023 17,918 8.29 17,918 4,539 October 2, 2023 - October 31, 2023 19,199 7.83 19,199 4,389 November 1, 2023 - November 30, 2023 42,291 7.68 42,291 14,065 December 1, 2023 - December 29, 2023 539,138 7.88 539,138 9,827 Total 899,085 $ 8.24 899,085 (1) The average price paid per share as reflected above includes broker fees and commissions.
NOL can generally be carried forward to offset both ordinary taxable income and capital gains in future years. The Tax Cuts and Jobs Act (“TCJA”) along with revisions made by the Coronavirus Aid, Relief, and Economic Security Act (“CARES”) reduced the deduction for NOLs to 80% of taxable income and granted an indefinite carryforward period.
NOL can generally be carried forward to offset both ordinary taxable income and capital gains in future years. The Tax Cuts and Jobs Act (“TCJA”) along with revisions made by the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act reduced the deduction for NOLs to 80% of taxable income and granted an indefinite carryforward period.
Our 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock, or Series C Preferred Stock, is listed on the NYSE and trades under the symbol “ACRPrC.” We have declared and paid the specified quarterly dividend per share of $0.5390625 through January 2023. No dividends are currently in arrears on the Series C Preferred Stock.
Our 8.625% Fixed-to-Floating Series C Cumulative Redeemable Preferred Stock, or Series C Preferred Stock, is listed on the NYSE and trades under the symbol “ACRPrC.” We have declared and paid the specified quarterly dividend per share of $0.5390625 through January 2024. No dividends are currently in arrears on the Series C Preferred Stock.
In May 2021, and subsequently in June 2021, we issued the 7.875% Series D Cumulative Redeemable Preferred Stock, or Series D Preferred Stock, which is listed on the NYSE and trades under the symbol “ACRPrD.” On October 4, 2021, we and our Manager entered into an Equity Distribution Agreement with JonesTrading Institutional Services LLC, as placement agent, pursuant to which we may issue and sell from time to time up to 2.2 million shares of the Series D Preferred Stock.
Our 7.875% Series D Cumulative Redeemable Preferred Stock, or Series D Preferred Stock, is listed on the NYSE and trades under the symbol “ACRPrD.” In October 2021, we and our Manager entered into an Equity Distribution Agreement with JonesTrading Institutional Services LLC, as placement agent, pursuant to which we may issue and sell from time to time up to 2.2 million shares of the Series D Preferred Stock.
Manager Incentive Plan at December 31, 2022: (a) (b) (c) Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans Excluding Securities Reflected in Column (a) Equity compensation approved by security holders: Restricted stock (1) 583,333 N/A Equity compensation plans not approved by security holders N/A N/A Total 583,333 1,034,155 (1) All restricted stock awards consist of unvested shares.
Manager Incentive Plan at December 31, 2023: (a) (b) (c) Plan Category Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights Weighted-Average Exercise Price of Outstanding Options, Warrants and Rights Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans Excluding Securities Reflected in Column (a) Equity compensation approved by security holders: Restricted stock (1) 416,675 N/A Equity compensation plans not approved by security holders N/A N/A Total 416,675 1,034,155 (1) All restricted stock awards consist of unvested shares.
Performance Graph The following line graph presentation compares cumulative total shareholder returns on our common stock with the Russell 2000 Index and the FTSE NAREIT All REIT Index for the period from December 31, 2017 to December 31, 2022.
Performance Graph The following line graph presentation compares cumulative total shareholder returns on our common stock with the Russell 2000 Index and the FTSE NAREIT All REIT Index for the period from December 31, 2018 to December 31, 2023.
The graph and table assume that $100 was invested in each of our common stock, the Russell 2000 Index and the FTSE NAREIT All REIT Index on December 31, 2017, and that all dividends were reinvested. This data is furnished by the Research Data Group. *$100 invested on December 31, 2017 in stock or index, including reinvestment of dividends.
The graph and table assume that $100 was invested in each of our common stock, the Russell 2000 Index and the FTSE NAREIT All REIT Index on December 31, 2018, and that all dividends were reinvested. This data is furnished by the Research Data Group.
In December 2021, we issued additional Series D Preferred Stock pursuant to this agreement. We have declared and paid the specified quarterly dividend per share of $0.4921875 through January 2023. No dividends are currently in arrears on the Series D Preferred Stock. Issuer Purchases of Equity Securities In March 2016, our Board approved a securities repurchase program.
We have declared and paid the specified quarterly dividend per share of $0.4921875 through January 2024. No dividends are currently in arrears on the Series D Preferred Stock. Issuer Purchases of Equity Securities In March 2016, our Board approved a securities repurchase program.
The following table summarizes our current and estimated tax loss carryforwards (dollars in millions): Tax Year Recognized REIT (QRS) Tax Loss Carryforwards TRS Tax Loss Carryforwards Tax Asset Item Operating Capital Operating Capital Net Operating Loss Carryforwards: Cumulative as of 2021 2021 Return $ 46.6 $ — $ 60.1 $ — Net Capital Loss Carryforwards: Cumulative as of 2021 2021 Return — 121.9 — 1.0 Total tax asset estimates $ 46.6 $ 121.9 $ 60.1 $ 1.0 Useful life Unlimited 5 years Various 5 years During the year ended December 31, 2021, we generated $1.1 million of taxable income which was offset by our cumulative NOL, leaving $46.6 million to carry forward to future years.
The following table summarizes our current and estimated tax loss carryforwards (dollars in millions): Tax Year Recognized REIT (QRS) Tax Loss Carryforwards TRS Tax Loss Carryforwards Tax Asset Item Operating Capital Operating Capital Net Operating Loss Carryforwards: Cumulative as of 2022 2022 Return $ 46.6 $ — $ 60.2 $ — Net Capital Loss Carryforwards: Cumulative as of 2022 2022 Return — 121.9 — 1.0 Total tax asset estimates $ 46.6 $ 121.9 $ 60.2 $ 1.0 Useful life Unlimited 5 years Various 5 years At December 31, 2023, we had $46.6 million of cumulative NOL to carry forward to future years.
We also recognized net capital loss carryforwards as finalized in our 2020 tax return. During the year ended December 31, 2022, all taxable income was distributed in the form of a preferred share distribution, and therefore, no common share distribution was required.
We also recognized net capital loss carryforwards as finalized in our 2020 tax return. During the year ended December 31, 2023, all taxable income was offset by our NOLs, and therefore, no common share distribution was required.
The following table summarizes certain information about our 2005 Stock Incentive Plan, Third Amended and Restated Omnibus Equity Compensation Plan and ACRES Commercial Realty Corp.
Such information was obtained through our registrar and transfer agent. (Back to Index) 41 (Back to Index) The following table summarizes certain information about our 2005 Stock Incentive Plan, Third Amended and Restated Omnibus Equity Compensation Plan and ACRES Commercial Realty Corp.
In November 2021, our Board authorized and approved the continued use of our existing share repurchase program to repurchase an additional $20.0 million of our outstanding common stock. At December 31, 2022, $7.2 million remains available under this repurchase program.
In November 2021, our Board authorized and approved the continued use of our existing share repurchase program to repurchase an additional $20.0 million of our outstanding common stock. In November 2023, our Board authorized and approved the repurchase of an additional $10.0 million of outstanding shares of both common and preferred stock.
These tax assets are analyzed and disclosed quarterly in our financial statements. As of December 31, 2022, our TRSs have $39.9 million of pre-TCJA NOLs, some of which are set to expire beginning in 2044, $20.2 million of NOLs with an indefinite carryforward period and net capital loss carryforwards of $1.0 million.
At December 31, 2023, our TRSs have $60.2 million of NOLs comprising: $39.8 million of pre-TCJA NOLs, some of which are set to expire beginning in 2044 and $20.4 million of NOLs with an indefinite carryforward period. Additionally, our TRSs have cumulative total net capital losses of $1.0 million, which are set to expire on December 31, 2024.
The 206 holders of record include Cede & Co., which holds shares as nominee for The Depository Trust Company, which itself holds shares on behalf of the beneficial owners of our common stock. Such information was obtained through our registrar and transfer agent.
At March 4, 2024, there were 7,748,393 shares of common stock outstanding held by 196 holders of record. The 196 holders of record include Cede & Co., which holds shares as nominee for The Depository Trust Company, which itself holds shares on behalf of the beneficial owners of our common stock.
Additionally, $15.0 million of net capital gains was reported on our tax return for the year ended December 31, 2021. This was offset with our cumulative total net capital losses, leaving $121.9 million to carry forward to future years. No capital losses expired during 2021. We also have tax assets in our taxable REIT subsidiaries (“TRS”).
Additionally, we have cumulative total net capital losses of $121.9 million, which are set to expire on December 31, 2025. We also have tax assets in our taxable REIT subsidiaries (“TRS”). These tax assets are analyzed and disclosed quarterly in our financial statements.